Propanc Biopharma, Inc. (PPCB) Current Reports & Earnings Releases
| Filed | Form | Items | Filing |
|---|---|---|---|
| 2026-07-14 | 8-K | Officer / Director Changes, Financial Statements & Exhibits | SEC |
| 2026-02-26 | 8-K | Officer / Director Changes, Financial Statements & Exhibits | SEC |
| 2026-01-07 | 8-K | Listing Notice | SEC |
| 2025-11-10 | 8-K | Unregistered Sales, Charter Amendments, Financial Statements & Exhibits | SEC |
| 2025-10-14 | 8-K | Material Agreement, Financial Statements & Exhibits | SEC |
| 2025-08-19 | 8-K | Material Agreement, Officer / Director Changes, Other Events, Financial Statements & Exhibits | SEC |
| 2025-08-13 | 8-K | Officer / Director Changes | SEC |
| 2025-07-30 | 8-K | Material Agreement, Direct Financial Obligation, Unregistered Sales, Financial Statements & Exhibits | SEC |
| 2025-07-22 | 8-K | Material Agreement, Direct Financial Obligation, Unregistered Sales, Financial Statements & Exhibits | SEC |
| 2025-06-27 | 8-K | Material Agreement, Direct Financial Obligation, Unregistered Sales, Financial Statements & Exhibits | SEC |
| 2025-06-18 | 8-K | Material Agreement, Direct Financial Obligation, Unregistered Sales, Financial Statements & Exhibits | SEC |
| 2025-06-02 | 8-K | Material Agreement, Direct Financial Obligation, Unregistered Sales, Financial Statements & Exhibits | SEC |
| 2025-05-08 | 8-K | Material Agreement, Direct Financial Obligation, Unregistered Sales, Financial Statements & Exhibits | SEC |
| 2025-04-21 | 8-K | Material Agreement, Direct Financial Obligation, Unregistered Sales, Financial Statements & Exhibits | SEC |
| 2025-03-18 | 8-K | Material Agreement, Direct Financial Obligation, Unregistered Sales, Financial Statements & Exhibits | SEC |
| 2025-02-12 | 8-K | Material Agreement, Direct Financial Obligation, Unregistered Sales, Financial Statements & Exhibits | SEC |
| 2024-12-20 | 8-K | Material Agreement, Direct Financial Obligation, Unregistered Sales, Financial Statements & Exhibits | SEC |
| 2024-12-06 | 8-K | Material Agreement, Direct Financial Obligation, Financial Statements & Exhibits | SEC |
| 2024-09-27 | 8-K | Material Agreement, Direct Financial Obligation, Unregistered Sales, Financial Statements & Exhibits | SEC |
| 2024-08-30 | 8-K | Material Agreement, Direct Financial Obligation, Financial Statements & Exhibits | SEC |
| 2024-08-15 | 8-K | Material Agreement, Direct Financial Obligation, Unregistered Sales, Financial Statements & Exhibits | SEC |
| 2024-08-07 | 8-K | Material Agreement, Direct Financial Obligation, Unregistered Sales, Financial Statements & Exhibits | SEC |
| 2024-07-02 | 8-K | Material Agreement, Direct Financial Obligation, Unregistered Sales, Financial Statements & Exhibits | SEC |
| 2024-06-21 | 8-K | Material Agreement, Direct Financial Obligation, Unregistered Sales, Financial Statements & Exhibits | SEC |
| 2024-06-12 | 8-K | Material Agreement, Direct Financial Obligation, Unregistered Sales, Financial Statements & Exhibits | SEC |
| 2024-06-05 | 8-K | Material Agreement, Direct Financial Obligation, Unregistered Sales, Financial Statements & Exhibits | SEC |
| 2024-05-16 | 8-K | Material Agreement, Direct Financial Obligation, Financial Statements & Exhibits | SEC |
| 2024-04-22 | 8-K | Material Agreement, Direct Financial Obligation, Unregistered Sales, Financial Statements & Exhibits | SEC |
| 2024-04-10 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2024-03-11 | 8-K | Material Agreement, Direct Financial Obligation, Unregistered Sales, Financial Statements & Exhibits | SEC |
Sourced from SEC EDGAR 8-K/6-K filings. 8-K is the current-report form for US domestic issuers (Item 2.02 = earnings release); 6-K is the equivalent for foreign private issuers, including ADRs. Originals live on sec.gov.